Nonclinical Development of BCG Replacement Vaccine Candidates.

Item

http://www.wikidata.org/entity/Q35890636

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Nonclinical Development of BCG Replacement Vaccine Candidates.

@ast

Nonclinical Development of BCG Replacement Vaccine Candidates.

@en

type

Item

label

Nonclinical Development of BCG Replacement Vaccine Candidates.

@ast

Nonclinical Development of BCG Replacement Vaccine Candidates.

@en

prefLabel

Nonclinical Development of BCG Replacement Vaccine Candidates.

@ast

Nonclinical Development of BCG Replacement Vaccine Candidates.

@en

P1476

Nonclinical Development of BCG Replacement Vaccine Candidates.

@en

P2093

Bernd Eisele

http://www.w3.org/2001/XMLSchema#string

David Hokey

http://www.w3.org/2001/XMLSchema#string

David McCown

http://www.w3.org/2001/XMLSchema#string

Dominick Laddy

http://www.w3.org/2001/XMLSchema#string

John Fulkerson

http://www.w3.org/2001/XMLSchema#string

Kamalakannan Velmurugan

http://www.w3.org/2001/XMLSchema#string

Leander Grode

http://www.w3.org/2001/XMLSchema#string

Megan Fitzpatrick

http://www.w3.org/2001/XMLSchema#string

Michael J Brennan

http://www.w3.org/2001/XMLSchema#string

Reginald Kidd

http://www.w3.org/2001/XMLSchema#string

P2860

A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

pH dependence of listeriolysin O aggregation and pore-forming ability

Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis

Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis

Influence of BCG vaccine strain on the immune response and protection against tuberculosis.

rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector

Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.

A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity.

P304

120-138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/VACCINES1020120

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin Gengenbacher

P577

2013-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256446633

http://www.w3.org/2001/XMLSchema#string

P698

26343962

http://www.w3.org/2001/XMLSchema#string

P932

4515585

http://www.w3.org/2001/XMLSchema#string